Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

19. März 2026 17:57 ET | Quelle: Netcapital Inc.

Netcapital Reports Third Quarter Fiscal 2026 Financial Results and Provides Corporate Update

Key milestones include acquisition of Iverson Design and signing PureWave Hydrogen as first tokenization clientManagement to host business update conference call tomorrow at 10:00 am ET BOSTON, MA,...
19. März 2026 08:00 ET | Quelle: Chemomab Therapeutics Ltd.

Chemomab Therapeutics Announces Year End and Fourth Quarter 2025 Financial Results and Provides a Corporate Update

2025 was a critical year for Chemomab and nebokitug. Partnering discussions continue to advance along with preparations to launch the PSC Phase 3 trial.
13. März 2026 07:00 ET | Quelle: AC Immune SA

AC Immune Reports Full Year 2025 Financial Results and Provides a Corporate Update

AC Immune Reports Full Year 2025 Financial Results and Provides a Corporate Update Phase 2 interim results suggest treatment with active immunotherapy ACI-7104 may slow the progression of Parkinson’s...
11. März 2026 09:15 ET | Quelle: Psyence Biomedical Ltd.

Corporate Update: Psyence BioMed Advances Vertically Integrated Pharmaceutical Platform Following PsyLabs Export Milestone

NEW YORK, March 11, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”) today reinforced how its strategic investment in PsyLabs strengthens its...
27. Februar 2026 16:03 ET | Quelle: NurExone Biologic Inc

NurExone to Showcase Its Regenerative Medicine Platform at NANO.IL.2026 and Advanced Therapies Congress in March 2026 and Provides Corporate Update

TORONTO and HAIFA, Israel, Feb. 27, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biopharmaceutical company developing...
18. Februar 2026 08:45 ET | Quelle: Propanc Biopharma, Inc.

Propanc Biopharma Provides Corporate Update and Reports Half Yearly 2025/26 Results

We are pleased with advancements made with our R&D programs and... our lead asset PRP which we are preparing for our world-first, Phase 1b, clinical study
06. Februar 2026 11:55 ET | Quelle: Nordicus Partners Corporation

Nordicus Partners Corporation Corporate Update

BEVERLY HILLS, California, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in supporting...
30. Januar 2026 16:03 ET | Quelle: NurExone Biologic Inc

NurExone Appoints Eyal Gabbai to Board, Adding Large-Scale Healthcare System and Capital Markets Expertise

TORONTO and HAIFA, Israel, Jan. 30, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) today announced changes to its board of...
13. Januar 2026 08:45 ET | Quelle: Propanc Biopharma, Inc.

Propanc Biopharma Provides Shareholder Update

In this update, Mr. Nathanielsz highlights the significant progress achieved during 2025 and outlines the Company’s ambitious plans for 2026.
31. Dezember 2025 08:00 ET | Quelle: CHAR Technologies Ltd.

CHAR Tech Provides Year-End Update and Lists on the Frankfurt Stock Exchange

TORONTO, Dec. 31, 2025 (GLOBE NEWSWIRE) -- CHAR Technologies Ltd. (“CHAR Tech” or the “Company”) (TSXV:YES), a leader in sustainable energy solutions, is pleased to provide a year-end corporate...

Nächste Seite